Aclaris Therapeutics (ACRS) Gross Profit Growth (3y) (2019 - 2026)
Aclaris Therapeutics (ACRS) Gross Profit Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 299.84% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 45.27% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 803.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 59.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 80.79% |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | 19.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.49% |
| Mar 31, 2026 | -2.36% |
| Dec 31, 2025 | -51.95% |
| Sep 30, 2025 | -46.56% |
| Jun 30, 2025 | 39.99% |
| Mar 31, 2025 | 47.12% |
| Dec 31, 2024 | 189.11% |
| Sep 30, 2024 | 87.51% |
| Jun 30, 2024 | 56.30% |
| Mar 31, 2024 | 40.33% |
| Dec 31, 2023 | 285.51% |
| Sep 30, 2023 | 218.92% |
| Jun 30, 2023 | 7.97% |
| Mar 31, 2023 | 131.85% |
| Dec 31, 2022 | 365.88% |
| Sep 30, 2022 | 386.65% |
| Jun 30, 2022 | 84.29% |
| Mar 31, 2022 | 74.59% |
| Dec 31, 2021 | 30.06% |
| Sep 30, 2021 | 8.78% |